THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
$33,059,642
| Recipient | EITR BIOLOGICS, INC. UEI HX49LZLY32G5 |
|---|---|
| Award ID | 75A50123C00060 |
| Award amount | $33,059,642 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | 3650 |
| Set-aside | Unrestricted |
| Start date | Sep 22, 2023 |
| End date | Sep 30, 2027 |
| Place of performance | SAN DIEGO, CA |
| Record updated | Jul 28, 2026 |
View the official award record
More awards won by EITR BIOLOGICS, INC.
NOVEL NANOTHERAPEUTICS
Department of Defense · $1,864,756 · Sep 20, 2024
NOVEL CELL SORTING
Department of Defense · $1,105,767 · Nov 28, 2022
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
Department of Defense · $926,999 · Feb 1, 2026
NOVEL NANOTHERAPEUTIC APPROACHES PENETRATING THE OUTER LAYERS OF THE BACTERIUM AND TARGETING OUTER MEMBRANE PROTEINS FOR THE TREATMENT OF PNEUMONIC PLAGUE FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
Department of Defense · $750,000 · Sep 1, 2023
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
Department of Defense · $729,721 · Dec 6, 2023
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids